Human trials show reduced fasting glucose and HbA1c in people with type 2 diabetes when using Gymnema Sylvestre.
Clinical trials typically use 400-1,000mg daily — considerably more than Gymnema's likely individual share of SugarReset's 200mg total blend.
It's traditionally used to help reduce sugar cravings and support pancreatic function.